The Great Cannabis Split: 5 Surprising Realities of the 2026 Federal Reclassification

In April 2026, the DOJ enacted a tectonic shift by reclassifying medical marijuana to Schedule III. While this historic move validates cannabis’s medical utility and eliminates crippling Section 280E taxes for medical operators, recreational cannabis remains trapped in Schedule I. This unprecedented “partial rescheduling” creates a bizarre dual-status reality where the exact same plant is treated as both a recognized medicine and a prohibited narcotic, forcing businesses to navigate a highly complicated legal landscape

Read More →

Blowing Smoke or Breaking Ground? The New Marijuana Rescheduling Order

Recent federal directives aim to transition cannabis from a Schedule I to a Schedule III controlled substance under the Controlled Substances Act. This historic shift acknowledges the drug’s medical utility while promising significant tax relief for businesses by removing the burden of IRC Section 280(e). Despite these financial benefits, the move does not federally legalize recreational use or resolve long-standing hurdles in banking and trademark registration.

Read More →